Gene · 652995
Papers3,485
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 3,485
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and Validation of 7-lncRNA Signature of Epigenetic Disorders by Comprehensive Epigenetic Analysis. | Dis Markers | 2022 | 35237359 | PubTator, text mining | PubMed |
| Prognostication of Pancreatic Cancer Using The Cancer Genome Atlas Based Ferroptosis-Related Long Non-Coding RNAs. | Front Genet | 2022 | 35237306 | PubTator, text mining | PubMed |
| Identification of a Novel Immune-Related lncRNA CTD-2288O8.1 Regulating Cisplatin Resistance in Ovarian Cancer Based on Integrated Analysis. | Front Genet | 2022 | 35237300 | PubTator, text mining | PubMed |
| The long and short non-coding RNAs modulating EZH2 signaling in cancer. | J Hematol Oncol | 2022 | 35236381 | PubTator, text mining | PubMed |
| lncNBAT1/APOBEC3A is a mediator of HBX-induced chemoresistance in diffuse large B cell lymphoma cells. | Mol Ther Nucleic Acids | 2022 | 35228900 | PubTator, text mining | PubMed |
| The paradoxical functions of long noncoding RNAs in hepatocellular carcinoma: Implications in therapeutic opportunities and precision medicine. | Genes Dis | 2022 | 35224152 | PubTator, text mining | PubMed |
| The Role of Long Non-Coding RNAs in the Tumor Immune Microenvironment. | Front Immunol | 2022 | 35222443 | PubTator, text mining | PubMed |
| MicroRNAs and 'Sponging' Competitive Endogenous RNAs Dysregulated in Colorectal Cancer: Potential as Noninvasive Biomarkers and Therapeutic Targets. | Int J Mol Sci | 2022 | 35216281 | PubTator, text mining | PubMed |
| Emerging Concepts on the Role of Extracellular Vesicles and Its Cargo Contents in Glioblastoma-Microglial Crosstalk. | Mol Neurobiol | 2022 | 35212938 | PubTator, text mining | PubMed |
| Differential Expression of RAD51AP1 in Ovarian Cancer: Effects of siRNA In Vitro. | J Pers Med | 2022 | 35207688 | PubTator, text mining | PubMed |
| Long Noncoding RNA LINC02470 Sponges MicroRNA-143-3p and Enhances SMAD3-Mediated Epithelial-to-Mesenchymal Transition to Promote the Aggressive Properties of Bladder Cancer. | Cancers (Basel) | 2022 | 35205713 | PubTator, text mining | PubMed |
| Impact of Non-Coding RNAs on Chemotherapeutic Resistance in Oral Cancer. | Biomolecules | 2022 | 35204785 | PubTator, text mining | PubMed |
| The lncRNAs/miR-30e/CHI3L1 Axis Is Dysregulated in Systemic Sclerosis. | Biomedicines | 2022 | 35203705 | PubTator, text mining | PubMed |
| C-C Chemokine Receptor 7 in Cancer. | Cells | 2022 | 35203305 | PubTator, text mining | PubMed |
| Artemisinins in Combating Viral Infections Like SARS-CoV-2, Inflammation and Cancers and Options to Meet Increased Global Demand. | Front Plant Sci | 2022 | 35197994 | PubTator, text mining | PubMed |
| Functional Interactions Between lncRNAs/circRNAs and miRNAs: Insights Into Rheumatoid Arthritis. | Front Immunol | 2022 | 35197980 | PubTator, text mining | PubMed |
| The emerging role non-coding RNAs in B cell-related disorders. | Cancer Cell Int | 2022 | 35193592 | PubTator, text mining | PubMed |
| AFAP1 antisense RNA 1 promotes retinoblastoma progression by sponging microRNA miR-545-3p that targets G protein subunit beta 1. | Bioengineered | 2022 | 35193469 | PubTator, text mining | PubMed |
| Classification of Hepatocellular Carcinoma Based on N6-Methylandenosine-Related lncRNAs Profiling. | Front Mol Biosci | 2022 | 35187083 | PubTator, text mining | PubMed |
| Identification of Combinations of Plasma lncRNAs and mRNAs as Potential Biomarkers for Precursor Lesions and Early Gastric Cancer. | J Oncol | 2022 | 35186077 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/652995/papers?page=50